Vitamin K2-7 PCD Pharma Franchise Company
Cafoli Lifecare is a Vitamin K2-7 PCD pharma franchise company offering 5 Vitamin K2-7 formulations manufactured at WHO-GMP certified facilities. The range is focused on the bone-health segment, with menaquinone-7 supplied in softgel and tablet presentations, typically in combination with calcium and Vitamin D3, and is available to franchise partners under exclusive monopoly rights.
What is Vitamin K2-7?
Vitamin K2-7, or menaquinone-7 (MK-7), is a long-chain, fat-soluble member of the Vitamin K2 family. It acts as a cofactor for the enzyme gamma-glutamyl carboxylase, which carboxylates vitamin K-dependent proteins including osteocalcin in bone and matrix Gla protein in vascular tissue; carboxylated osteocalcin is required to bind calcium into the bone matrix. MK-7 has a notably longer plasma half-life than Vitamin K1, which is why it is the preferred form in once-daily bone-health supplementation. Further compound data is available from PubChem.
Dosage Forms Available
The Cafoli Lifecare Vitamin K2-7 range is available as Softgel and Tablets across 5 SKUs. Softgels suit the fat-soluble profile of menaquinone-7, while tablets are used mainly in calcium-plus-D3-plus-K2-7 bone-health combinations.
Therapeutic Applications
Vitamin K2-7 formulations are used as adjunctive therapy in osteoporosis and osteopenia, in post-menopausal bone loss, in calcium and Vitamin D supplementation regimens where improved calcium utilisation is intended, and in general bone-health maintenance in older adults.
Principal prescribers are orthopaedic surgeons, rheumatologists, gynaecologists, endocrinologists and general physicians.
Why Vitamin K2-7 is a High-Potential Molecule for Distributors
The calcium supplement market in India is saturated and price-driven, and plain calcium-plus-D3 is close to a commodity. Vitamin K2-7 is the ingredient that lets a distributor step out of that fight. Because MK-7 carboxylates osteocalcin — the protein that actually binds calcium into bone — a K2-7 combination carries a mechanistic story that a plain calcium tablet cannot match, and it supports a materially better margin per strip.
The range is deliberately small at 5 SKUs, and that is the point: this is a premium, differentiated add-on rather than a volume commodity. It fits naturally alongside an existing calcium or orthopaedic portfolio, and orthopaedic and gynaecology prescribing for osteoporosis is chronic and repeat-refill by nature, which protects off-take once the brand is established in a territory.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers exclusive monopoly rights by district, WHO-GMP certified manufacturing and DCGI-approved formulations. Partners receive full promotional inputs — visual aids, MR bags, samples, prescription pads and product literature — alongside transparent net rates and dependable dispatch. Cafoli Lifecare works with 1000+ franchise partners across India.
References
- PubChem — Menaquinone-7 (CID 5282793)
- MedlinePlus — Vitamin K
- PubMed — Menaquinone-7 and bone health literature
Our formulations of Vitamin K2-7 find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: